Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Quantify the expression of metabolizing enzymes and…

U.S. Food and Drug Administration·United States of America

Quantify the expression of metabolizing enzymes and transporter proteins in lung, eye and skin tissue in relevant animal models and humans

Rolling / TBD close$200k – $500kGrants Notice
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The purpose of this funding opportunity is to quantify the protein levels of potential metabolizing enzymes and transporters in rabbit eye and human eye tissue, human skin tissue, or human lung tissue using advanced techniques. The experimental data collected will be implemented into existing modeling platforms to allow for virtual BE assessments. The goal is to improve the predictive power of PBPK models to inform decisions on generic ophthalmic, dermal, and orally inhaled drug product development and to perform virtual BE assessments in support of regulatory decisions. • The funding opportunity is for research to quantify metabolizing enzymes and transporters in various tissues. • The experimental data will be used to enhance existing modeling platforms. • The goal is to improve the predictive power of PBPK models for drug product development and regulatory decisions. • The funding opportunity is sponsored by the Food and Drug Administration.

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

Shashi Malhotra(Grants Management Specialist)

[email protected]

(240) 402-7592

Key dates

Opened
5/25/2021
Closes
Rolling / TBD

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
FOR-FD-20-025

Budget estimate

$200,000 – $500,000

The budget for this grant is not explicitly stated, but based on the scope of the research and the funding agency, it is likely to be in the range of $200,000 to $500,000. This estimate is based on the fact that the research involves advanced techniques and the implementation of experimental data into existing modeling platforms, which may require significant resources and personnel. Additionally, the funding agency is a government agency, which may have specific budget constraints and guidelines for grant funding.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 68%

Elucidation and Validation of the role of Transporters in the Placenta, Lactating Mammary Gland, Developing Gut, and Blood Brain Barrier

Closes 10/19/2027Opened 7/16/2026

U.S. Food and Drug Administration·United States of America

65% match

Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Required)

Rolling / TBD closeOpened 11/24/2023

U.S. National Institutes of Health·United States of America

64% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: National Somatic Mosaicism Commons Data Analysis & Organizational Center (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

64% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Tissue Procurement Center (R24 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. Department Of Defense·Virginia

64% match

High-throughput Unmasking of Biological Interactomes with Binding Landscape Emulators (HUBBLE)

Closes 11/5/2026Opened 10/8/2026

U.S. Department Of Health And Human Services·United States of America

64% match

Pre-Clinical Models of Infectious Diseases

Closes 12/7/2026Opened 10/19/2026

U.S. National Institutes of Health·United States of America

63% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Experimental and Computational Technology Development (RM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

63% match

Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)

Closes 11/23/2026Opened 5/28/2025

U.S. National Institutes of Health·United States of America

63% match

Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)

Closes 1/7/2027Opened 8/8/2023

U.S. National Institutes of Health·United States of America

63% match

Transformative Technologies for Experimental and Computational RNome Characterization and Functional Analysis

Closes 2/14/2027Opened 8/5/2026

U.S. National Institutes of Health·United States of America

63% match

Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)

Closes 11/16/2027Opened 10/28/2024

U.S. National Institutes of Health·United States of America

63% match

Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)

Closes 1/29/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

63% match

Transformative Non-Invasive/Minimally Invasive Technologies for Imaging the Olfactory System Across Scales (R01 CT Optional)

Closes 8/21/2028Opened 7/17/2025

U.S. Department Of Health And Human Services·Maryland

63% match

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Seeks Industry Partners for Clinical Research Collaborations on Therapeutics, Diagnostics or Devices for Childhood Cholestatic Liver Diseases

Closes 5/31/2029Opened 9/30/2024

U.S. National Institutes of Health·United States of America

63% match

Mechanistic Toxicology of METALS: Metal Exposure, Transport, Action, Localization, and Susceptibility (RP1 Clinical Trial Not Allowed)

Closes 1/4/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

62% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

62% match

Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 3/17/2021

U.S. National Institutes of Health·United States of America

62% match

Resource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed)

Closes 9/28/2028Opened 6/9/2025

U.S. National Institutes of Health·United States of America

62% match

NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)

Closes 5/8/2028Opened 7/8/2025

U.S. National Institutes of Health·United States of America

62% match

Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)

Closes 12/23/2027Opened 11/22/2024

U.S. National Institutes of Health·United States of America

62% match

Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)

Closes 11/23/2026Opened 5/28/2025

U.S. National Institutes of Health·United States of America

62% match

CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)

Closes 11/5/2028Opened 6/30/2025

U.S. National Institutes of Health·United States of America

62% match

Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)

Closes 12/23/2027Opened 1/24/2022

U.S. National Institutes of Health·United States of America

62% match

Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 7/22/2021

U.S. National Institutes of Health·United States of America

62% match

BRAIN Initiative: Development and Validation of Novel Tools and New Approaches for Neuroscience Research

Closes 6/9/2027Opened 6/24/2026